» Articles » PMID: 22131424

Alterations in Intrinsic Membrane Properties and the Axon Initial Segment in a Mouse Model of Angelman Syndrome

Overview
Journal J Neurosci
Specialty Neurology
Date 2011 Dec 2
PMID 22131424
Citations 81
Authors
Affiliations
Soon will be listed here.
Abstract

The axon initial segment (AIS) is the site of action potential initiation in neurons. Recent studies have demonstrated activity-dependent regulation of the AIS, including homeostatic changes in AIS length, membrane excitability, and the localization of voltage-gated Na(+) channels. The neurodevelopmental disorder Angelman syndrome (AS) is usually caused by the deletion of small portions of the maternal copy of chromosome 15, which includes the UBE3A gene. A mouse model of AS has been generated and these mice exhibit multiple neurological abnormalities similar to those observed in humans. We examined intrinsic properties of pyramidal neurons in hippocampal area CA1 from AS model mice and observed alterations in resting membrane potential, threshold potential, and action potential amplitude. The altered intrinsic properties in the AS mice were correlated with significant increases in the expression of the α1 subunit of Na/K-ATPase (α1-NaKA), the Na(+) channel NaV1.6, and the AIS anchoring protein ankyrin-G, as well as an increase in length of the AIS. These findings are the first evidence for pathology of intrinsic membrane properties and AIS-specific changes in AS, a neurodevelopmental disorder associated with autism.

Citing Articles

The Primary Cilia are Associated with the Axon Initial Segment in Neurons.

Wang H, Li Y, Li X, Sun Z, Yu F, Pashang A Adv Sci (Weinh). 2025; 12(9):e2407405.

PMID: 39804991 PMC: 11884599. DOI: 10.1002/advs.202407405.


Transcriptomic alterations in APP/PS1 mice astrocytes lead to early postnatal axon initial segment structural changes.

Benitez M, Retana D, Ordonez-Gutierrez L, Colmena I, Gomez M, Alvarez R Cell Mol Life Sci. 2024; 81(1):444.

PMID: 39485512 PMC: 11530419. DOI: 10.1007/s00018-024-05485-9.


Insights into the structure and function of the hippocampus: implications for the pathophysiology and treatment of autism spectrum disorder.

Long J, Li H, Liu Y, Liao X, Tang Z, Han K Front Psychiatry. 2024; 15:1364858.

PMID: 38716113 PMC: 11074454. DOI: 10.3389/fpsyt.2024.1364858.


Na+/K+-ATPase: ion pump, signal transducer, or cytoprotective protein, and novel biological functions.

Huang S, Dong W, Lin X, Bian J Neural Regen Res. 2024; 19(12):2684-2697.

PMID: 38595287 PMC: 11168508. DOI: 10.4103/NRR.NRR-D-23-01175.


UBE3A: The Role in Autism Spectrum Disorders (ASDs) and a Potential Candidate for Biomarker Studies and Designing Therapeutic Strategies.

Roy B, Amemasor E, Hussain S, Castro K Diseases. 2024; 12(1).

PMID: 38248358 PMC: 10814747. DOI: 10.3390/diseases12010007.


References
1.
Deng V, Matagne V, Banine F, Frerking M, Ohliger P, Budden S . FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice. Hum Mol Genet. 2007; 16(6):640-50. DOI: 10.1093/hmg/ddm007. View

2.
Yang Y, Lacas-Gervais S, Morest D, Solimena M, Rasband M . BetaIV spectrins are essential for membrane stability and the molecular organization of nodes of Ranvier. J Neurosci. 2004; 24(33):7230-40. PMC: 6729762. DOI: 10.1523/JNEUROSCI.2125-04.2004. View

3.
Matsuura T, Sutcliffe J, Fang P, Galjaard R, Jiang Y, Benton C . De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome. Nat Genet. 1997; 15(1):74-7. DOI: 10.1038/ng0197-74. View

4.
Gustin R, Bichell T, Bubser M, Daily J, Filonova I, Mrelashvili D . Tissue-specific variation of Ube3a protein expression in rodents and in a mouse model of Angelman syndrome. Neurobiol Dis. 2010; 39(3):283-91. PMC: 2922926. DOI: 10.1016/j.nbd.2010.04.012. View

5.
van Spronsen M, Hoogenraad C . Synapse pathology in psychiatric and neurologic disease. Curr Neurol Neurosci Rep. 2010; 10(3):207-14. PMC: 2857788. DOI: 10.1007/s11910-010-0104-8. View